Company Filing History:
3 out of 82 
1 out of 97 
Years Active: 2011-2020
Title: Teizo Fujita: Innovator in Genetic Modification
Introduction
Teizo Fujita is a prominent inventor based in Fukushima, Japan. He has made significant contributions to the field of genetic modification, particularly in the development of non-human mammals and cells. With a total of three patents to his name, Fujita's work has implications for understanding and treating disorders related to the complement system.
Latest Patents
Fujita's latest patents focus on genetically modified non-human mammals and cells. These genetically modified mammals lack the mannan binding lectin associated serine protease MASP-2. The methods and constructs for their production are also described in his patents. Such mammals serve as valuable models for studying disorders of the complement system and for identifying potential treatments. Additionally, his patents include mammals that may lack the associated protein MAp19, which can also result in the absence of MASP-2.
Career Highlights
Throughout his career, Teizo Fujita has worked with notable institutions, including the University of Leicester and Omeros Corporation. His research has advanced the understanding of genetic modifications and their applications in medical science.
Collaborations
Fujita has collaborated with esteemed colleagues such as Hans-Wilhelm Schwaeble and Cordula Margaret Stover. These partnerships have further enriched his research and contributions to the field.
Conclusion
Teizo Fujita's innovative work in genetic modification has paved the way for new models in medical research. His patents reflect a commitment to advancing scientific knowledge and improving treatment options for complex disorders.